Match Document Document Title
US20140011986 CATALYTIC OR PHOTOCATALYTIC PREPARATION METHOD OF PARYLENE AF4  
The present invention disclosed a preparation method of parylene AF4, which provides a reactant and a reducing agent with the use of catalyst or exposure to UV light with photo-initiator, to...
US20080119447 6-ALKOXYALKYL ESTRADIOL DERIVATIVES AND METHODS OF USE  
A compound having the structure: wherein R1, R2, R3, R4, R5, R6, R7 and R9 are independently hydrogen, C1 to C6 alkyl or substituted alkyl, halogen, sulfate or glucuronide moieties; the symbol...
US20110077227 NOVEL LUPANE DERIVATIVES  
The invention relates to 21-keto triterpene compounds of formula (I): wherein R1, X, and Y are as defined herein, and pharmaceutically acceptable salts and solvates thereof. These compounds...
US20050222107 Novel process  
A process for preparing fluticasone propionate as crystalline polymorphic Form 1 which comprises reacting a compound of formula (II) or a salt thereof with a compound of formula LCH2F wherein L...
US20150079519 PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE RESIN, AND PHOTOSENSITIVE COMPOSITION  
A photosensitive compound represented by formula (1) or formula (2). (Chemical formula 1) (In formula (1) and formula (2), n is an integer of 1-3; R1 is a linear or branched alkyl group having 1-6...
US20090275543 Modified Glycosaminoglycans, Pharmaceutical Compositions and Methods for Oral Delivery Thereof  
This invention provides a composition comprising a depolymerized glycosaminoglycan or derivative thereof covalently linked to a bile acid. This invention also provides a pharmaceutical composition...
US20070096082 Crosslinkable arylamine compounds and conjugated oligomers or polymers based thereon  
Crosslinkable arylamine compounds; oligomers and polymers prepared from such crosslinkable arylamine compounds; films and coatings; and multilayer electronic devices comprising such films are...
US20120157421 17Beta-Alkyl-17Alpha-oxy-estratrienes  
The invention relates to 17β-alkyl-17α-oxy-oestratrienes of the formula (I), to processes for their preparation, to the use of the 17β-alkyl-17α-oxy-oestratrienes for preparing pharmaceuticals and...
US20070088013 (S)-6-methyloxaalkyl exemestane compounds and related methods of use  
6-Methyloxaalkyl exemestane compounds and related compositions, as can be used, chemotherapeutically, to inhibit growth and proliferation of cancer cells.
US20090118248 3-Alpha-hydroxy 21-n-heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof  
The invention relates to a novel multi step process of making compounds of Formula I: wherein R1 is an alkoxy group and R2 is an optionally substituted, N-attached heteroaryl. The hydrogen at the...
US20140107328 CHEMOSELECTIVE ENRICHMENT FOR COMPOUND ISOLATION  
Chemoselective isolation of aliphatic hydroxyl group-containing and aromatic hydroxyl group-containing compounds is accomplished via formation of polymeric siloxyl ethers. Chemoselective release...
US20090325918 Synthesis and separation of optically active isomers and cyclopropyl derivatives of spironolactone and their biological action  
Methods for separation and synthesis of the optically active 7-thioester isomers and mono or bis-cyclopropyl derivatives of spironolactone are provided. Preferred stereoisomerically purified...
US20090275542 AZAHETEROCYCLYL DERIVATIVES OF ANDROSTANES AND ANDROSTENES AS MEDICAMENTS FOR CARDIOVASCULAR DISORDERS  
Compounds of formula (I) wherein: the groups are as defined in the description, are useful for the preparation of medicaments for the treatment of cardiovascular disorders, in particular heart...
US20120209016 Exemestane and its Intermediates and Methods of Making the Same  
A method is provided for preparing an aromatase inhibitor of formula (I) wherein each of R1, R2, R3, R4, independently, is hydrogen, halogen or C1-C6 alkyl. In one form, the aromatase inhibitor is...
US20140148606 ANTI-TUMOR EFFECTS OF ALLOSTERIC FOCAL ADHESION KINASE INHIBITOR, METHYL VIOLET DERIVATIVES  
Disclosed is a methyl violet derivative having inhibitory activity against allosteric focal adhesion kinase (FAK) and is useful as an agent for preventing or treating cancer.
US20130172587 Process for the Preparation of Fluticasone Propionate  
The present invention relates to a process for the preparation of steroidal 17β-carboxylic thioates. More particularly the present invention relates to a convenient and efficient synthesis of...
US20090012286 PROCESS FOR THE PREPARATION OF 17-(3-HYDROXYPROPYL)-17-HYDROXYSTEROIDS  
The present invention relates to a process for the preparation of 17α-(3-hydroxypropyl)-17β-hydroxysteroids of the formula I starting from 17-ketosteroids of the formula III via the intermediates...
US20060063944 Estrone derivatives and process for producing same  
A compound of formula (I) (where X1 and X2 represent independently a hydrogen atom or a group of formula (II) R1 represents a linear or branched halogenoalkyl group having 1-7 carbon atoms; Ra...
US20150239925 Process for Preparing 11-Methylene-18-Methyl-Estr-4-En-3, 17-Dione, Useful as Intermediate Compound for the Synthesis of Molecules Having Pharmacological Activity  
There is described a process for the industrial synthesis of 11-methylene-18-methyl-estr-4-en-3,17-dione, a compound having the structure formula (I) depicted below: (Formula I) (I) useful as...
US20130324748 PROCESS FOR PREPARATION OF LEVONORGESTREL  
The present invention provides an improved process for preparation of levonorgestrel (3) which comprises of hydrolysis of 13β-ethyl-3-methoxy-17α-ethynyl-gona-2,5(10)-dien-17β-ol (2) with an acid...
US20100151002 Guggulphospholipid Methods and Compositions  
The present invention relates to the methods for preparing synthetic guggulphospholipids, their fatty acid analogues and other bioactive molecules. The present invention relates to E-guggulsterone...
US20100221213 Y-SHAPE BRANCHED HYDROPHILIC POLYMER DERIVATIVES, THEIR PREPARATION METHODS, CONJUGATES OF THE DERIVATIVES AND DRUG MOLECULES, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE CONJUGATES  
The present invention relates to Y-shape branched PEG derivatives of formulae (I) to (IV). The present invention also relates to conjugates of these Y-shape derivatives and drug molecules,...
US20110224180 NOVEL CHOLEST-4-EN-3-ONE OXIME DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND PREPARATION METHOD  
The present invention relates to novel chemical compounds, in particular cholest-4-en-3-one oxime derivatives and to the use thereof as medicaments, especially as cytoprotective medicaments, in...
US20090209506 AMINO DERIVATIVES OF BETA-HOMOANDROSTANES AND BETA-HETEROANDROSTANES  
New aminoalkoxyimino derivatives at position 3 of substituted B-homoandrostanes and B-heteroandrostanes, processes for their preparation, and to pharmaceutical compositions containing them for the...
US20090177001 NOVEL PROCESS AND INTERMEDIATES  
The present invention relates to a process for the preparation of steroidal 17β-carboxylic thioates. More particularly the present invention relates to a convenient and efficient synthesis of...
US20050119240 1-methyl-20-epi-vitamin d derivative  
A vitamin D derivative which has a methyl group in the 1-position and has an epi form in the 20-position. The vitamin D derivative is represented by the general formula (1): wherein R represents...
US20130085125 METHODS FOR THE SYNTHESIS AND PURIFICATION OF DEOXYCHOLIC ACID  
Synthesis and purification of deoxycholic acid and its salts are provided.
US20120129837 Derivatives of Fluorene, Anthracene, Xanthene, Dibenzosuberone and Acridine and Uses Thereof  
Chemical agents, such as disulfonamide derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine, and similar heterocyclic ring structures, including salts thereof, that act as...
US20060091365 Near-infrared absorbing compound and near-infrared absorbing filter using same  
A near-infrared absorbing filter which does not contain antimony, arsenic or the like and is excellent in heat resistance is disclosed. The near-infrared absorbing filter is characterized by...
US20100152145 USE OF 3-ALPHA-ANDROSTANEDIOL, OPTIONALLY IN COMBINATION WITH A PDE5 INHIBITOR, IN THE TREATMENT OF SEXUAL DYSFUNCTION  
The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of 3-alpha-androstanediol, preferably in combination with a type 5...
US20100130458 Polymorphs of fluticasone furoate and process for preparation thereof  
Provided are polymorphs of fluticasone furoate and processes for preparation thereof.
US20110201577 PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF OSELTAMIVIR AND ANALOGS THEREOF  
The present application relates to processes for the preparation of oseltamivir and the H3PO4 salt of oseltamivir, Tamiflu®. The application further relates to novel intermediate compounds and to...
US20140343023 ROR GAMMA MODULATORS  
The present invention relates to compounds of formula I, or a pharmaceutically acceptable salt thereof, for use in the treatment or prevention, suppression or amelioration of a disease mediated by...
US20080275259 Process for preparing aromatase inhibitors  
A process of making an aromatase inhibitor of formula (I) wherein each of R1, R2, R3, and R4, independently, is hydrogen, halogen, or C1-C6 alkyl, comprising reacting a compound of formula (II)...
US20070164251 High-temperature metal-organic acceptor magnets  
A stable magnet having a high Tc is provided. The stable magnet is synthesized from an at least one ion of a metal from a metal-containing precursor and molecules of an organic compound in a metal...
US20070167417 Process for the production of a sterol-rich composition  
The invention relates to a process for the production of a sterol ester-rich composition. A sterol composition, a glyceride composition, a fatty acid alkyl ester and an esterification catalyst are...
US20070232577 Synthetic pentacyclic triterpenoids and derivatives of betulinic acid and betulin  
The present invention comprises small molecule inhibitors of cell proliferative conditions, in particular cancer and conditions associated with cancer. For example, associated malignancies include...
US20100324003 AMINOOXIME DERIVATIVES OF 2- AND/OR 4-SUBSTITUTED ANDROSTANES AND ANDROSTENES AS MEDICAMENTS FOR CARDIOVASCULAR DISORDERS  
New aminooxime derivatives at position 3 of 2- and/or 4-substituted androstanes and androstenes, processes for their preparation, and to pharmaceutical compositions containing them for the...
US20130096094 Derivatives of 3-O-(3',3'-dimethylsuccinyl)-betulinic acid  
The present invention relates to compounds of the following formula (I): or a pharmaceutically acceptable salt thereof, a stereoisomer or a mixture of stereoisomers in any proportion, in...
US20090124588 Androstane 17-Alpha-Carbonate for Use in the Treatment of Inflammatory and Allergic Conditions  
The present invention is directed to compounds of formula (I): wherein R1 represents a 1,1-dimethylethyl group or a 1,1-dimethylpropyl groupand physiologically acceptable solvates thereof,...
US20070287846 Process for the Esterification of a Carbothioic Acid  
A process for preparing compounds of formula [II] by esterification of the C-17 hydroxyl group of 6α,9α-difluoro-11α,17α-dihydroxy-16α-methyl-3-oxoandrosta-1, 4-diene-17β-carbothioic acid, the...
US20070274980 Compositions of less immunogenic and long-circulating protein-lipid complexes  
Provided are lipidic particles comprising phopatidylcholine, phosphatidylinositol and cholesterol. Also provided are compositions comprising the lipidic particles and having associated therewith...
US20140088053 INHIBITORS OF 17Beta-HSD1, 17Beta-HSD3 AND 17Beta-HSD10  
The present application discloses 17β hydroxy steroid dehydrogenase (17β HSD) type 1, 3, 10 inhibitors and use thereof (alone and in combination) in the treatment of cancer and other afflictions....
US20090105198 NOVEL ESTROGENIC COMPOUNDS  
Novel estrogenic compounds of Formula I are provided. wherein the bond represented by the wavy line may be a single or double bond such that when the wavy line is a single bond, R1 is selected...
US20070299268 Process for the Preparation of Estrone and/or Estradiol-Derivates  
Process for the preparation of a compound of general formula (II) wherein R1 and R2 independently are hydrogen or a hydroxy- or hydrocarbyl group; or wherein R1 and R2 together are a double bonded...
US20060252948 Production method of steroid compound  
An object of the present invention is to provide a novel method for producing a steroid compound. The present invention provides a method for producing 3,7-dioxo-5β-cholanic acid or ester...
US20100311993 PROCESS FOR PREPARING AROMATIASE INHIBITOR EXEMESTANE  
The present invention discloses modified process for preparing aromatase inhibitor Exemestane involving suitable oxidizing agents in suitable solvents.
US20060211670 Antitumoral18a-homoestra-1,3,5(10)-trien-3yl 2-substituted sulfamates  
The invention relates to the use of compounds of a general formula (I), wherein R2, R14 to R17 and X groups have the following significance: R2 is C1-C5-Alkyl, C1-C5-Alkoxy or a —O—CNFmHo rest,...
US20110236602 PHOTOACTIVE MATERIALS  
Diamine compounds, which in particular are useful as precursors for the production of liquid crystal alignment layers, are represented by the general formula I: whereinA1 represents an organic...
US20100240916 PROCESS FOR OBTAINING STEROIDAL PHOSPHATE COMPOUNDS  
A process for obtaining 21-disodium phosphate pregnane derivative compounds of formula (I), wherein X═R═H or X═F and R=α-CH3 or X═F and R=β-CH3 comprises spray drying a solution comprising...